An observational study in Gastroesophageal Reflux Disease, Barrett Esophagus and Laryngopharyngeal Reflux, sponsored by Johns Hopkins University. Enrolling by invitation at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.
Sponsored by Johns Hopkins University · Observational
A multi-center, multi-year registry of patients with gastroesophageal reflux disease (GERD) undergoing diagnostic evaluation and/or treatment of GERD and associated diseases and complications.
This registry is a prospective, multicenter registry of patients undergoing diagnostic evaluation and/or treatment of gastroesophageal reflux disease and associated diseases and complications.
Patients who are eligible will have disease and therapy-specific data collected throughout treatment and long-term (5-year) follow-up.
Electronic data capture via REDCap will be utilized for all sites.
56 studies on the registry are indexed under Laryngopharyngeal Reflux; 8 are open to participants now.
Browse Laryngopharyngeal Reflux studies →Johns Hopkins University is the lead sponsor of 1,815 studies on the registry; 315 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Compared within Laryngopharyngeal Reflux, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Gastroesophageal Reflux. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Patients referred by physicians having diagnostic evaluation or treatment for GERD.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Demographic and clinical data obtained via chart review and questionnaires
Establish a registry with collected data related to patients undergoing diagnostic evaluation and treatment of GERD and its associated diseases in multiple academic and community settings.
Time frame: 5 years
Plan to share: Yes — Research projects will be submitted to host (currently JHU) and accepted project will be granted access to read only de-identified database.
Supporting information: Study protocol, Informed consent form
Time frame: minimum 6 years
Access criteria: Project submission to PI and or Heartburn Registry management team then if project accepted, security clearance and enrollment in REDCap and tutorial completions.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.